Ascites Market Research Report- Global Forecast till 2023

Ascites Market Research Report- Global Forecast till 2023

ID: MRFR/HC/1377-CRR | January, 2018 | Region: Global | 85 pages | Cooked Research Reports

Global Ascites Market Research Report: By Type (Transudative, Exudate Ascites), Diagnosis (Ultrasound, CT Scan, Laparoscopy, Angiography), Treatment (Surgeries, others), End Users (Ambulatory Surgical Centers, Hospitals, Clinics) – Forecast till 2023 



Market Scenario


Ascites is an abnormal accumulation of fluid in the abdominal cavity. Liver cirrhosis is the most common case of ascites. Its presence is a sign of significant portal hypertension. Other less common factors that may contribute to ascites development are heart failure, kidney failure, cancers, and infection in the pancreas. Malignant ascites has a characteristic role in the progression of ovarian cancer. Malignancy-related ascites have also been observed in malignancies of breast, lung, pancreas, gastric, and liver. Ascites can be detected by physical examination at a volume greater than 1.5 ascites. For a smaller amount of fluid, ultrasound and CT scan are preferred.


Notably, rising prevalence of cirrhosis is the key factors driving the ascites market. As per the study published in Hepatology journal in 2016, it is found that prevalence of the chronic liver disease is higher among Japanese Americans i.e. 6.9%. It is also stated that in whites, alcoholic liver disease was observed as the most common cause of cirrhosis i.e. 38.2%, whereas hepatitis C virus was most common in African Americans i.e. 29.8%


Improvement in reimbursement policies and increasing occurrence of cancer across the globe are also fuelling the market growth. According to a study published in the Cancer Biology & Medicine journal in 2017, it is found that ovarian cancer is the seventh most frequently diagnosed cancer among women in the world with an estimation of 239,000 new cases, and 152,000 deaths worldwide annually.


However, complications associated with ascites treatment may hinder the growth of the market over the forecast period. According to a study published in the Canadian Journal of Gastroenterology and Hepatology in 2016, serial large volume paracentesis (LVP) is considered as the first-line treatment for refractory ascites, and is also performed in an outpatient every 2 weeks. But there are certain complications associated with LVP such as bleeding, catheter fragmentation into the abdominal wall, and small bowel perforation.


The global ascites market is expected to grow at a CAGR of 4.0% during the forecast period 2017-2023. 


Intended Audience



  • Medical Devices Companies

  • Hospitals & Clinics

  • Diagnostic Centers

  • Research and Development (R&D) Companies

  • Government Research Institute

  • Academic Institutes and Universities 


Figure: Global Ascites Market by Type Market Share, 2016 (%)

Global Ascites Market


Sources: Annual reports, Press release, White paper, Company presentation


 


Segmentation


The global ascites market is segmented on the basis of type, diagnosis, treatment, and end user.


On the basis of the type, the market is classified into transudative ascites, and exudate ascites.


On the basis of the diagnosis, the market is segmented into ultrasound, CT scan, laparoscopy, angiography, and others.


On the basis of the treatment, the market is segmented into surgeries and others. The surgeries segment is further sub-segmented into peritoneovenous shunting, liver transplantation, transjugular intrahepatic portosystemic shunt (TIPS), and other surgeries.


On the basis of the end -users, the market is segmented into hospital, and clinics, ambulatory surgical centers, diagnostic centers, and others.


Key Findings



  • The global ascites market is expected to reach USD 3710.4 million by 2023 at a CAGR of 4.0%.

  • On the basis of the diagnosis, the ultrasound segment is expected to command the largest market share of 9% over the review period and it is also expected to grow at the fastest CAGR of 4.4% during the forecast period 2017-2023

  • On the basis of the type, exudate ascites is expected to command the largest market share of 55.8% over the review period and it is also expected to grow at the fastest CAGR of 4.4% during the forecast period 2017-2023

  • The Americas hold the largest share of the global ascites market and is expected to reach USD 1,292.2 million by 2023

  • Asia Pacific is the fastest growing market, which is expected to grow at a CAGR of 4.5% over the 2017-2023 


Regional Analysis


The Americas dominate the ascites market owing to the well-developed technology, high healthcare expenditure, rising prevalence of cirrhosis, and the presence of the leading players in the region. According to the data suggested by the Centers for Disease Control and Prevention in 2015, around 1.6 % adults have been diagnosed with the chronic liver disease in the United States i.e. 3.9 million. It is also stated that from 2000 to 2015 death rates due to the chronic liver disease and cirrhosis was increased by 31% in the United States among individuals aged 45–64 years.


Europe holds the second position in the ascites market. It is expected that the support provided by the government bodies for research & development and increasing number of surgeries drives the market in this region. Liver is also very prevalent in European region. Owing to the increasing alcohol consumption and obesity, liver cirrhosis is the third most common cause of premature mortality in the UK as compared to other countries in Western Europe, suggested by a study published in BMJ Open in 2017


Asia Pacific region is projected to be the fastest growing region during the forecast period. Rapidly improving technology and the presence of huge patient pool drive the growth of this market in Asia Pacific region.


The Middle East and Africa hold the least share of the ascites market owing to the presence of poor and slow developing countries, especially, in African region.


Key Players


Some of key the players in the ascites market are Sequana Medical, BioVie, PharmaCyte Biotech Inc., Fresenius SE & Co. KGaA, BD, GI Supply, Medtronic plc, and others.


Research Methodology



Ascites Market methodology


Sources: Annual reports, Press release, White paper, and Company presentation




License

Single User Enterprise User (Buy Premium Reports Chapterwise)
Currency

TABLE OF CONTENTS

2.1 Research Objective 15

2.2 Assumptions & Limitations 15

2.2.1 Assumptions 15

2.2.2 Limitations 15

2.3 Market Structure 16

3.1 Introduction 17

3.1.1 Primary Research Methodology 18

3.1.2 Secondary Research Methodology 19

3.1.3 Market Share Analysis 20

3.1.4 Trade Analysis 20

3.1.5 Market Pricing Approach 21

4.1 Introduction 22

4.2 Drivers 23

4.2.1 Rising Prevalence of Cirrhosis (Impact Weightage: 35%) 23

4.2.2 Improvement in Reimbursement Policies (Impact Weightage: 30%) 24

4.2.3 Increasing Occurrence of Cancer (Impact Weightage: 35%) 25

4.3 Restraints 26

4.3.1 Complications associated with the ascites treatment 26

4.4 Opportunity 27

4.4.1 Development of Innovative Treatment Options 27

4.5 Macroeconomic Indicators 27

5.1 Porter’s Five Forces Model 28

5.1.1 Bargaining Power of Suppliers 29

5.1.2 Bargaining Power of Buyers 29

5.1.3 Threat of New Entrants 29

5.1.4 Threat of Substitutes 29

5.1.5 Intensity of Rivalry 29

5.2 Value Chain Analysis: Global Ascites Market 30

5.2.1 R&D and Designing 30

5.2.2 Manufacturing 31

5.2.3 Distribution & Sales 31

5.2.4 Post-sales Monitoring 31

5.3 Demand & Supply: Gap Analysis 32

5.4 Pricing Analysis 32

6.1 Introduction 33

6.2 Transudative Ascites 34

6.3 Exudate Ascites 35

7.1 Introduction 36

7.2 Ultrasound 37

7.3 CT scan 38

7.4 Laparoscopy 38

7.5 Angiography 39

8.1 Introduction 40

8.2 Surgeries 42

9.1 Introduction 43

9.2 Hospitals & Clinics 44

9.3 Ambulatory Surgical Center 45

9.4 Diagnostic Centres 45

10.1 Introduction 46

10.2 Americas 48

10.2.1 North America 51

10.2.2 South America 57

10.3 Europe 67

10.3.1 Western Europe 70

10.3.2 Eastern Europe 84

10.4 Asia Pacific 86

10.4.1 China 89

10.4.2 Japan 91

10.4.3 India 93

10.4.4 Australia 95

10.4.5 Republic of Korea 97

10.4.6 Rest of Asia Pacific 99

10.5 Middle East & Africa 101

10.5.1 Middle East 104

10.5.2 Africa 118

11.1 Sequana Medical 120

11.1.1 Company Overview 120

11.1.2 Financials 120

11.1.3 Products 120

11.1.4 Strategy 120

11.1.5 Key Developments 120

11.2 BioVie 121

11.2.1 Company Overview 121

11.2.2 Financials 121

11.2.3 Products 121

11.2.4 Strategy 121

11.2.5 Key Developments 121

11.3 PharmaCyte Biotech Inc. 122

11.3.1 Company Overview 122

11.3.2 Financials 122

11.3.3 Products 122

11.3.4 Strategy 122

11.3.5 Key Developments 122

11.4 Fresenius SE & Co. KGaA 123

11.4.1 Company Overview 123

11.4.2 Financials 123

11.4.3 Products 123

11.4.4 Strategy 123

11.4.5 Key Developments 123

11.5 BD 124

11.5.1 Company Overview 124

11.5.2 Financials 124

11.5.3 Products 124

11.5.4 Strategy 124

11.5.5 Key Developments 124

11.6 GI Supply 125

11.6.1 Company Overview 125

11.6.2 Financials 125

11.6.3 Products 125

11.6.4 Strategy 125

11.6.5 Key Developments 125

11.7 Medtronic 126

11.7.1 Company Overview 126

11.7.2 Financials 126

11.7.3 Products 126

11.7.4 Strategy 126

11.7.5 Key Developments 126

12.1 Key Findings 127

12.1.1 From CEO’s View Point 127

13.1 Discussion Blue Print 128

TABLE 1 PRIMARY INTERVIEWS 18

TABLE 2 SAMPLE SIZE DETERMINATION OF END-USERS (HOSPITALS, CLINICS) 19

TABLE 3 GLOBAL ASCITES MARKET BY TYPES 2014-2023 (USD MILLION) 33

TABLE 4 GLOBAL ASCITES MARKET FOR TRANSUDATIVE ASCITES 2014-2023 (USD MILLION) 34

TABLE 5 GLOBAL ASCITES MARKET FOR EXUDATE ASCITES 2014-2023 (USD MILLION) 35

TABLE 6 GLOBAL ASCITES MARKET BY DIAGNOSIS 2014-2023 (USD MILLION) 36

TABLE 7 GLOBAL ASCITES MARKET FOR ULTRASOUND 2014-2023 (USD MILLION) 37

TABLE 8 GLOBAL ASCITES MARKET FOR CT SCAN 2014-2023 (USD MILLION) 38

TABLE 9 GLOBAL ASCITES MARKET FOR LAPAROSCOPY 2014-2023 (USD MILLION) 38

TABLE 10 GLOBAL ASCITES MARKET FOR ANGIOGRAPHY 2014-2023 (USD MILLION) 39

TABLE 11 GLOBAL ASCITES MARKET BY TREATMENT 2014-2023 (USD MILLION) 41

TABLE 12 GLOBAL ASCITES MARKET FOR SURGERIES 2014-2023 (USD MILLION) 42

TABLE 13 GLOBAL ASCITES MARKET BY END USERS 2014-2023 (USD MILLION) 43

TABLE 14 GLOBAL ASCITES MARKET FOR HOSPITALS & CLINICS 2014-2023 (USD MILLION) 44

TABLE 15 GLOBAL ASCITES MARKET FOR AMBULATORY SURGICAL CENTER 2014-2023 (USD MILLION) 45

TABLE 16 GLOBAL ASCITES MARKET FOR DIAGNOSTIC CENTRES 2014-2023 (USD MILLION) 45

TABLE 17 GLOBAL ASCITES MARKET BY REGIONS 2014-2023 (USD MILLION) 46

TABLE 18 AMERICAS ASCITES MARKET BY REGIONS 2014-2023 (USD MILLION) 48

TABLE 19 AMERICAS ASCITES MARKET BY TYPES 2014-2023 (USD MILLION) 49

TABLE 20 AMERICAS ASCITES MARKET BY DIAGNOSIS 2014-2023 (USD MILLION) 49

TABLE 21 AMERICAS ASCITES MARKET BY TREATMENT 2014-2023 (USD MILLION) 50

TABLE 22 AMERICAS ASCITES MARKET BY END USERS 2014-2023 (USD MILLION) 50

TABLE 23 NORTH AMERICA ASCITES MARKET BY TYPES 2014-2023 (USD MILLION) 51

TABLE 24 NORTH AMERICA ASCITES MARKET BY DIAGNOSIS 2014-2023 (USD MILLION) 51

TABLE 25 NORTH AMERICA ASCITES MARKET BY TREATMENT 2014-2023 (USD MILLION) 52

TABLE 26 NORTH AMERICA ASCITES MARKET BY END USERS 2014-2023 (USD MILLION) 52

TABLE 27 US ASCITES MARKET BY TYPES 2014-2023 (USD MILLION) 53

TABLE 28 US ASCITES MARKET BY DIAGNOSIS 2014-2023 (USD MILLION) 53

TABLE 29 US ASCITES MARKET BY TREATMENT 2014-2023 (USD MILLION) 54

TABLE 30 US ASCITES MARKET BY END USERS 2014-2023 (USD MILLION) 54

TABLE 31 CANADA ASCITES MARKET BY TYPES 2014-2023 (USD MILLION) 55

TABLE 32 CANADA ASCITES MARKET BY DIAGNOSIS 2014-2023 (USD MILLION) 55

TABLE 33 CANADA ASCITES MARKET BY TREATMENT 2014-2023 (USD MILLION) 56

TABLE 34 CANADA ASCITES MARKET BY END USERS 2014-2023 (USD MILLION) 56

TABLE 35 SOUTH AMERICA ASCITES MARKET BY TYPES 2014-2023 (USD MILLION) 57

TABLE 36 SOUTH AMERICA ASCITES MARKET BY DIAGNOSIS 2014-2023 (USD MILLION) 57

TABLE 37 SOUTH AMERICA ASCITES MARKET BY TREATMENT 2014-2023 (USD MILLION) 58

TABLE 38 SOUTH AMERICA ASCITES MARKET BY END USERS 2014-2023 (USD MILLION) 58

TABLE 39 BRAZIL ASCITES MARKET BY TYPES 2014-2023 (USD MILLION) 59

TABLE 40 BRAZIL ASCITES MARKET BY DIAGNOSIS 2014-2023 (USD MILLION) 59

TABLE 41 BRAZIL ASCITES MARKET BY TREATMENT 2014-2023 (USD MILLION) 60

TABLE 42 BRAZIL ASCITES MARKET BY END USERS 2014-2023 (USD MILLION) 60

TABLE 43 COLOMBIA ASCITES MARKET BY TYPES 2014-2023 (USD MILLION) 61

TABLE 44 COLOMBIA ASCITES MARKET BY DIAGNOSIS 2014-2023 (USD MILLION) 61

TABLE 45 COLOMBIA ASCITES MARKET BY TREATMENT 2014-2023 (USD MILLION) 62

TABLE 46 COLOMBIA ASCITES MARKET BY END USERS 2014-2023 (USD MILLION) 62

TABLE 47 MEXICO ASCITES MARKET BY TYPES 2014-2023 (USD MILLION) 63

TABLE 48 MEXICO ASCITES MARKET BY DIAGNOSIS 2014-2023 (USD MILLION) 63

TABLE 49 MEXICO ASCITES MARKET BY TREATMENT 2014-2023 (USD MILLION) 64

TABLE 50 MEXICO ASCITES MARKET BY END USERS 2014-2023 (USD MILLION) 64

TABLE 51 REST OF SOUTH AMERICA ASCITES MARKET BY TYPES 2014-2023 (USD MILLION) 65

TABLE 52 REST OF SOUTH AMERICA ASCITES MARKET BY DIAGNOSIS 2014-2023 (USD MILLION) 65

TABLE 53 REST OF SOUTH AMERICA ASCITES MARKET BY TREATMENT 2014-2023 (USD MILLION) 66

TABLE 54 REST OF SOUTH AMERICA ASCITES MARKET BY END USERS 2014-2023 (USD MILLION) 66

TABLE 55 EUROPE ASCITES MARKET BY REGIONS 2014-2023 (USD MILLION) 67

TABLE 56 EUROPE ASCITES MARKET BY TYPES 2014-2023 (USD MILLION) 68

TABLE 57 EUROPE ASCITES MARKET BY DIAGNOSIS 2014-2023 (USD MILLION) 68

TABLE 58 EUROPE ASCITES MARKET BY TREATMENT 2014-2023 (USD MILLION) 69

TABLE 59 EUROPE ASCITES MARKET BY END USERS 2014-2023 (USD MILLION) 69

TABLE 60 WESTERN EUROPE ASCITES MARKET BY TYPES 2014-2023 (USD MILLION) 70

TABLE 61 WESTERN EUROPE ASCITES MARKET BY DIAGNOSIS 2014-2023 (USD MILLION) 70

TABLE 62 WESTERN EUROPE ASCITES MARKET BY TREATMENT 2014-2023 (USD MILLION) 71

TABLE 63 WESTERN EUROPE ASCITES MARKET BY END USERS 2014-2023 (USD MILLION) 71

TABLE 64 GERMANY ASCITES MARKET BY TYPES 2014-2023 (USD MILLION) 72

TABLE 65 GERMANY ASCITES MARKET BY DIAGNOSIS 2014-2023 (USD MILLION) 72

TABLE 66 GERMANY ASCITES MARKET BY TREATMENT 2014-2023 (USD MILLION) 73

TABLE 67 GERMANY ASCITES MARKET BY END USERS 2014-2023 (USD MILLION) 73

TABLE 68 FRANCE ASCITES MARKET BY TYPES 2014-2023 (USD MILLION) 74

TABLE 69 FRANCE ASCITES MARKET BY DIAGNOSIS 2014-2023 (USD MILLION) 74

TABLE 70 FRANCE ASCITES MARKET BY TREATMENT 2014-2023 (USD MILLION) 75

TABLE 71 FRANCE ASCITES MARKET BY END USERS 2014-2023 (USD MILLION) 75

TABLE 72 U.K. ASCITES MARKET BY TYPES 2014-2023 (USD MILLION) 76

TABLE 73 U.K. ASCITES MARKET BY DIAGNOSIS 2014-2023 (USD MILLION) 76

TABLE 74 U.K. ASCITES MARKET BY TREATMENT 2014-2023 (USD MILLION) 77

TABLE 75 U.K. ASCITES MARKET BY END USERS 2014-2023 (USD MILLION) 77

TABLE 76 ITALY ASCITES MARKET BY TYPES 2014-2023 (USD MILLION) 78

TABLE 77 ITALY ASCITES MARKET BY DIAGNOSIS 2014-2023 (USD MILLION) 78

TABLE 78 ITALY ASCITES MARKET BY TREATMENT 2014-2023 (USD MILLION) 79

TABLE 79 ITALY ASCITES MARKET BY END USERS 2014-2023 (USD MILLION) 79

TABLE 80 SPAIN ASCITES MARKET BY TYPES 2014-2023 (USD MILLION) 80

TABLE 81 SPAIN ASCITES MARKET BY DIAGNOSIS 2014-2023 (USD MILLION) 80

TABLE 82 SPAIN ASCITES MARKET BY TREATMENT 2014-2023 (USD MILLION) 81

TABLE 83 SPAIN ASCITES MARKET BY END USERS 2014-2023 (USD MILLION) 81

TABLE 84 REST OF WESTERN EUROPE ASCITES MARKET BY TYPES 2014-2023 (USD MILLION) 82

TABLE 85 REST OF WESTERN EUROPE ASCITES MARKET BY DIAGNOSIS 2014-2023 (USD MILLION) 82

TABLE 86 REST OF WESTERN EUROPE ASCITES MARKET BY TREATMENT 2014-2023 (USD MILLION) 83

TABLE 87 REST OF WESTERN EUROPE ASCITES MARKET BY END USERS 2014-2023 (USD MILLION) 83

TABLE 88 EASTERN EUROPE ASCITES MARKET BY TYPES 2014-2023 (USD MILLION) 84

TABLE 89 EASTERN EUROPEASCITES MARKET BY DIAGNOSIS 2014-2023 (USD MILLION) 84

TABLE 90 EASTERN EUROPEASCITES MARKET BY TREATMENT 2014-2023 (USD MILLION) 85

TABLE 91 EASTERN EUROPEASCITES MARKET BY END USERS 2014-2023 (USD MILLION) 85

TABLE 92 ASIA PACIFIC ASCITES MARKET BY REGIONS 2014-2023 (USD MILLION) 86

TABLE 93 ASIA PACIFIC ASCITES MARKET BY TYPES 2014-2023 (USD MILLION) 87

TABLE 94 ASIA PACIFIC ASCITES MARKET BY DIAGNOSIS 2014-2023 (USD MILLION) 87

TABLE 95 ASIA PACIFIC ASCITES MARKET BY TREATMENT 2014-2023 (USD MILLION) 88

TABLE 96 ASIA PACIFIC ASCITES MARKET BY END USERS 2014-2023 (USD MILLION) 88

TABLE 97 CHINA ASCITES MARKET BY TYPES 2014-2023 (USD MILLION) 89

TABLE 98 CHINA ASCITES MARKET BY DIAGNOSIS 2014-2023 (USD MILLION) 89

TABLE 99 CHINA ASCITES MARKET BY TREATMENT 2014-2023 (USD MILLION) 90

TABLE 100 CHINA ASCITES MARKET BY END USERS 2014-2023 (USD MILLION) 90

TABLE 101 JAPAN ASCITES MARKET BY TYPES 2014-2023 (USD MILLION) 91

TABLE 102 JAPAN HINA ASCITES MARKET BY DIAGNOSIS 2014-2023 (USD MILLION) 91

TABLE 103 JAPAN ASCITES MARKET BY TREATMENT 2014-2023 (USD MILLION) 92

TABLE 104 JAPAN ASCITES MARKET BY END USERS 2014-2023 (USD MILLION) 92

TABLE 105 INDIA ASCITES MARKET BY TYPES 2014-2023 (USD MILLION) 93

TABLE 106 INDIA HINA ASCITES MARKET BY DIAGNOSIS 2014-2023 (USD MILLION) 93

TABLE 107 INDIA ASCITES MARKET BY TREATMENT 2014-2023 (USD MILLION) 94

TABLE 108 INDIA ASCITES MARKET BY END USERS 2014-2023 (USD MILLION) 94

TABLE 109 AUSTRALIA ASCITES MARKET BY TYPES 2014-2023 (USD MILLION) 95

TABLE 110 AUSTRALIA HINA ASCITES MARKET BY DIAGNOSIS 2014-2023 (USD MILLION) 95

TABLE 111 AUSTRALIA ASCITES MARKET BY TREATMENT 2014-2023 (USD MILLION) 96

TABLE 112 AUSTRALIA ASCITES MARKET BY END USERS 2014-2023 (USD MILLION) 96

TABLE 113 REPUBLIC OF KOREA ASCITES MARKET BY TYPES 2014-2023 (USD MILLION) 97

TABLE 114 REPUBLIC OF KOREA HINA ASCITES MARKET BY DIAGNOSIS 2014-2023 (USD MILLION) 97

TABLE 115 REPUBLIC OF KOREA ASCITES MARKET BY TREATMENT 2014-2023 (USD MILLION) 98

TABLE 116 REPUBLIC OF KOREA ASCITES MARKET BY END USERS 2014-2023 (USD MILLION) 98

TABLE 117 REST OF ASIA PACIFIC ASCITES MARKET BY TYPES 2014-2023 (USD MILLION) 99

TABLE 118 REST OF ASIA PACIFIC HINA ASCITES MARKET BY DIAGNOSIS 2014-2023 (USD MILLION) 99

TABLE 119 REST OF ASIA PACIFIC ASCITES MARKET BY TREATMENT 2014-2023 (USD MILLION) 100

TABLE 120 REST OF ASIA PACIFIC ASCITES MARKET BY END USERS 2014-2023 (USD MILLION) 100

TABLE 121 MIDDLE EAST & AFRICA ASCITES MARKET BY REGIONS 2014-2023 (USD MILLION) 101

TABLE 122 MIDDLE EAST & AFRICA ASCITES MARKET BY TYPES 2014-2023 (USD MILLION) 102

TABLE 123 MIDDLE EAST & AFRICA ASCITES MARKET BY DIAGNOSIS 2014-2023 (USD MILLION) 102

TABLE 124 MIDDLE EAST & AFRICA ASCITES MARKET BY TREATMENT 2014-2023 (USD MILLION) 103

TABLE 125 MIDDLE EAST & AFRICA ASCITES MARKET BY END USERS 2014-2023 (USD MILLION) 103

TABLE 126 MIDDLE EAST ASCITES MARKET BY TYPES 2014-2023 (USD MILLION) 104

TABLE 127 MIDDLE EAST HINA ASCITES MARKET BY DIAGNOSIS 2014-2023 (USD MILLION) 104

TABLE 128 MIDDLE EAST ASCITES MARKET BY TREATMENT 2014-2023 (USD MILLION) 105

TABLE 129 MIDDLE EAST ASCITES MARKET BY END USERS 2014-2023 (USD MILLION) 105

TABLE 130 UAE ASCITES MARKET BY TYPES 2014-2023 (USD MILLION) 106

TABLE 131 UAE HINA ASCITES MARKET BY DIAGNOSIS 2014-2023 (USD MILLION) 106

TABLE 132 UAE ASCITES MARKET BY TREATMENT 2014-2023 (USD MILLION) 107

TABLE 133 UAE ASCITES MARKET BY END USERS 2014-2023 (USD MILLION) 107

TABLE 134 SAUDI ARABIA ASCITES MARKET BY TYPES 2014-2023 (USD MILLION) 108

TABLE 135 SAUDI ARABIA HINA ASCITES MARKET BY DIAGNOSIS 2014-2023 (USD MILLION) 108

TABLE 136 SAUDI ARABIA ASCITES MARKET BY TREATMENT 2014-2023 (USD MILLION) 109

TABLE 137 SAUDI ARABIA ASCITES MARKET BY END USERS 2014-2023 (USD MILLION) 109

TABLE 138 OMAN ASCITES MARKET BY TYPES 2014-2023 (USD MILLION) 110

TABLE 139 OMAN HINA ASCITES MARKET BY DIAGNOSIS 2014-2023 (USD MILLION) 110

TABLE 140 OMAN ASCITES MARKET BY TREATMENT 2014-2023 (USD MILLION) 111

TABLE 141 OMAN ASCITES MARKET BY END USERS 2014-2023 (USD MILLION) 111

TABLE 142 KUWAIT ASCITES MARKET BY TYPES 2014-2023 (USD MILLION) 112

TABLE 143 KUWAIT HINA ASCITES MARKET BY DIAGNOSIS 2014-2023 (USD MILLION) 112

TABLE 144 KUWAIT ASCITES MARKET BY TREATMENT 2014-2023 (USD MILLION) 113

TABLE 145 KUWAIT ASCITES MARKET BY END USERS 2014-2023 (USD MILLION) 113

TABLE 146 QATAR ASCITES MARKET BY TYPES 2014-2023 (USD MILLION) 114

TABLE 147 QATAR HINA ASCITES MARKET BY DIAGNOSIS 2014-2023 (USD MILLION) 114

TABLE 148 QATAR ASCITES MARKET BY TREATMENT 2014-2023 (USD MILLION) 115

TABLE 149 QATAR ASCITES MARKET BY END USERS 2014-2023 (USD MILLION) 115

TABLE 150 REST OF MIDDLE EAST ASCITES MARKET BY TYPES 2014-2023 (USD MILLION) 116

TABLE 151 REST OF MIDDLE EAST ASCITES MARKET BY DIAGNOSIS 2014-2023 (USD MILLION) 116

TABLE 152 REST OF MIDDLE EAST ASCITES MARKET BY TREATMENT 2014-2023 (USD MILLION) 117

TABLE 153 REST OF MIDDLE EAST ASCITES MARKET BY END USERS 2014-2023 (USD MILLION) 117

TABLE 154 AFRICA ASCITES MARKET BY TYPES 2014-2023 (USD MILLION) 118

TABLE 155 AFRICA ASCITES MARKET BY DIAGNOSIS 2014-2023 (USD MILLION) 118

TABLE 156 AFRICA ASCITES MARKET BY TREATMENT 2014-2023 (USD MILLION) 119

TABLE 157 AFRICA ASCITES MARKET BY END USERS 2014-2023 (USD MILLION) 119

FIGURE 1 GLOBAL ASCITES MARKET BY TYPE, 2016 (%) 14

FIGURE 2 GLOBAL ASCITES MARKET, BY DIAGNOSIS, 2016 (%) 14

FIGURE 3 RESEARCH METHODOLOGY 17

FIGURE 4 FIGURE 1 VALUE CHAIN: GLOBAL ASCITES MARKET 30

FIGURE 5 GLOBAL ASCITES MARKET BY TYPES 2016 & 2023 (USD MILLION) 34

FIGURE 6 GLOBAL ASCITES MARKET BY DIAGNOSIS 2016 & 2023 (USD MILLION) 37

FIGURE 7 GLOBAL ASCITES MARKET BY TREATMENT 2016 & 2023 (USD MILLION) 41

FIGURE 8 GLOBAL ASCITES MARKET BY END USERS 2016 & 2023 (USD MILLION) 44

FIGURE 9 GLOBAL ASCITES MARKET BY REGIONS MARKET SHARE 2016 (%) 47

FIGURE 10 AMERICAS ASCITES MARKET BY REGIONS MARKET SHARE 2016 (%) 48

FIGURE 11 EUROPE ASCITES MARKET BY REGIONS MARKET SHARE 2016 (%) 67

FIGURE 12 ASIA PACIFIC ASCITES MARKET BY REGIONS MARKET SHARE 2016 (%) 86

FIGURE 13 MIDDLE EAST & AFRICA ASCITES MARKET BY REGIONS MARKET SHARE 2016 (%) 101